Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,141
datasets available to search
ShareScore release 0.9.0
Dataset results
1,141 results for “adhd”
Supplementary file 29 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 29: Proportion of participants on methylphenidate with euphoria/hypomania </p>
Supplementary file 20 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 20: Proportion of participants on methylphenidate with fingernail biting</p>
Supplementary file 73 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 73: Proportion of participants on methylphenidate with nasopharyngitis</p>
Supplementary file 28 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 28: Proportion of participants on methylphenidate with emotional lability</p>
Supplementary file 71 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 71: Proportion of participants on methylphenidate with gastroenteritis</p>
Supplementary file 34 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 34: Proportion of participants on methylphenidate with irritability </p>
Supplementary file 67 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 67: Proportion of participants on methylphenidate with nausea </p>
Dataset: Challenges, Strengths, and Strategies of People with ADHD in Software Engineering: A Case Study
<p>This dataset accompanies the paper "Challenges, Strengths, and Strategies of People with ADHD in Software Engineering: A Case Study". It contains interview guides as well as anonymous interview transcripts for six interviewees who explicitly consented to the publication.</p> <p>Specifically:</p> <ul> <li>Interview transcripts are Excel files starting with "<strong>interview</strong>".</li> <li>The interview instruments used for the 19 interviews are named "<strong>interview_guide_professionals</strong>" followed by a version number. V1 was used for the first 3 interviews, V2 for the 9 following interviews, and V3 for the remaining 7.</li> <li><strong>manager_feedback_guide.pdf</strong> is the interview guide used for discussions with the 4 managers. The preliminary results we showed them are depicted in <strong>01_challenges_themes_relations_noStrat_v2</strong>, <strong>02_strengths_themes_relations_v1</strong> and <strong>02_strengths_themes_relations_v2</strong></li> <li><strong>consent_form.pdf</strong> is a PDF version of the online form used to handle consent and intake of interviewees.</li> </ul>
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT03260205. IPD Sharing: YES. Countries: 1. Publications: 1.
Sleep IntervEntion as Symptom Treatment for ADHD
ClinicalTrials.gov study NCT04723719. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT03327402. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
ClinicalTrials.gov study NCT03325881. IPD Sharing: YES. Countries: 1. Publications: 1.
Communication to Improve Shared Decision-Making in ADHD
ClinicalTrials.gov study NCT02716324. IPD Sharing: YES. Countries: 1. Publications: 6.
Supplementary file 15 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 15: Proportion of participants withdrawn from methylphenidate treatment due to hallucinations</p>
Supplementary file 45 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 45: Proportion of participants on methylphenidate with somnolence </p>
Supplementary file 53 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 53: Proportion of participants on methylphenidate with cough</p>
Wavelet variance coefficients of children and adolescents with and without ADHD
<p>Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that often persists into adulthood. One hallmark in the characterization of pathological processing in ADHD is that attention skills are not impaired per se but more inconsistent and with higher variability compared to typically developing children (TDC). Increased variability in ADHD patients has been found in reaction times, as well as resting-state fMRI (rs-fMRI) brain signals. High variability has been assumed to reflect occasional lapses in attention, linked to intrusions of distracting activity during task performance and/or reduced anti-correlation between regions in the DMN and attention networks. Therefore, Dajani et al. (2019) concluded that it is more likely the dynamics between and within neural networks [i.e., the variability of network processing across time- and frequency-scales], that are affected in ADHD, than functional connectivity [in terms of one coefficient describing the (averaged) correlation between two regions over time]. </p> <p>We determined wavelet variance to quantify these dynamics. We determined wVar at rest and under task in fMRI timeseries of regions of the DMN and the FPN in three different frequency bands: 0.02 to 0.04Hz, 0.04 to 0.08Hz, and 0.08-0.16Hz.</p> <p>We found that wVar differed group specifically between rest and task (significant group X condition interaction: whereas wVar was higher at rest compared to task in TDC, wVar was comparable or even decreased at rest in ADHD. For an external validation of group comparisons in wVar at rest, we determined wVar in rs-fMRI timeseries of a subsample of the Child Mind Institute data set (Functional Connectomes Project International Neuroimaging Data-Sharing Initiative http://dx.doi.org/10.15387/CMI_HBN (2017)). Results replicated our findings in terms of no significant group differences in wVar at rest in combination with similar or lower absolute values in ADHD patients compared to control subjects. </p> <p>In normal processing, high wVar at rest was interpreted as reflecting free fluctuating brain signaling, in comparison to small wVar under task indicating focussed processing. Thus, we conclude that wVar is a sensitive measure of cognitive processing and is even capable of detecting deviant processing in pathological brain function.</p>
Auditory time thresholds in the range of milliseconds but not seconds are impaired in ADHD
<p>Dataset related to: Auditory time thresholds in the range of milliseconds but not seconds are impaired in ADHD</p>
Examining the Use of VR as a Study Aid for University Students with ADHD Dataset
<p>This repository contains complementary information for the paper Examining the Use of VR as a Study Aid for University Students with ADHD. It includes the instructions for tutors during the experiment, the model for the interviews after each session, and the questionnaires.</p>
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT02083783. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.